the question is salient given that guideline updates from the European Society of Cardiology/European Association for the Study of Diabetes and the American Diabetes Association recommend these therapies as first-line agents in the treatment of drug-nave patients with type 2 diabetes and high or very high risk of a CV event [8, 9]
Aiming for Long-Term Health If your goal isnt just to lose weight but to improve your overall quality of life and reduce health risks like heart disease or stroke, this medication is a promising option
Results from the FLOW trial, which assessed semaglutide (Ozempic, Novo Nordisk) in adults with type 2 diabetes and CKD, were first presented at the European Renal Association Congress and published in The New England Journal of Medicine in May
District Court for the Eastern District of Pennsylvania, who is presiding over discovery into common issue that impact all claims and is expected to schedule a series of early bellwether test cases for trial
What to do instead: Let your hair air-dry when you can, use the lowest heat setting when styling, and try to space out chemical treatments
Theyve transformed diabetes care and opened new possibilities for long-term weight management, but they can be expensive without insurance